Association of estrogen receptor genes and schizophrenia: A preliminary study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 1-4

  Min, Jung Ah ^a   Kim, Jung Jin ^a   Pae, Chi Un ^b,c   Kim, Kyung Hee ^a   Lee, Chang Uk ^a   Lee, Chul ^a   Paik, In Ho ^d  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Keyo Hospital   (South Korea)

Author keywords

Estrogen; Gene; Polymorphism; Receptor; Schizophrenia

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; ARTICLE; CONTROLLED STUDY; ER ALPHA GENE; ER BETA GENE; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; SCHIZOPHRENIA;

ADULT; AGE OF ONSET; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; YOUNG ADULT;

EID: 82555187782     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.09.012     Document Type: Article

References (36)

1. Alkelai A., Lupoli S., Greenbaum L., Giegling I., Kohn Y., Sarner-Kanyas K. Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. FASEB J 2011, 25(11):4011-4023.
2. Amin Z., Canli T., Epperson C.N. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 2005, 4:43-58.
3. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., et al. Genome scan for susceptibility loci for schizophrenia. Neuropsychobiology 2000, 42:175-182.
4. Bellino S., Rocca P., Patria L., Marchiaro L., Rasetti R., Di Lorenzo R., et al. Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. J Clin Psychiatry 2004, 65:908-914.
5. Berman K.F., Schmidt P.J., Rubinow D.R., Danaceau M.A., Van Horn J.D., Esposito G., et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A 1997, 94:8836-8841.
6. Brown C.M., Suzuki S., Jelks K.A., Wise P.M. Estradiol is a potent protective, restorative, and trophic factor after brain injury. Semin Reprod Med 2009, 27:240-249.
7. Cai Q., Shu X.O., Jin F., Dai Q., Wen W., Cheng J.R., et al. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003, 12:853-859.
8. Choi T.Y., Kee B.S., Lee M.K., Park A.J., Kwak K.H., Nam B.Y., et al. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E in Korean schizophrenic patients. J Korean Neuropsychiatr Assoc 2002, 41:831-846.
9. Couse J.F., Korach K.S. Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann Endocrinol (Paris) 1999, 60:143-148.
10. Drago A., De Ronchi D., Serretti A. Incomplete coverage of candidate genes: a poorly considered bias. Curr Genomics 2007, 8:476-483.
11. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009, 35:528-548.
12. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog Neurobiol 2001, 63:29-60.
13. Gross G., Huber G. Schizophrenia: neurodevelopmental disorder or degenerative brain process?. Fortschr Neurol Psychiatr 2008, 76(Suppl 1):S57-S62.
14. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003, 28(Suppl 2):17-54.
15. Häfner H., Riecher-Rössler A., An Der Heiden W., Maurer K., Fätkenheuer B., Löffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993, 23:925-940.
16. Halbreich U., Kahn L.S. Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 2003, 28(Suppl 2):1-16.
17. Herrington D.M., Howard T.D. ER-alpha variants and the cardiovascular effects of hormone replacement therapy. Pharmacogenomics 2003, 4:269-277.
18. Kravitz H.M., Janssen I., Lotrich F.E., Kado D.M., Bromberger J.T. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife. Am J Med 2006, 119:S87-S93.
19. Levinson D.F., Holmans P., Straub R.E., Owen M.J., Wildenauer D.B., Gejman P.V., et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000, 67:652-663.
20. Lindholm E., Ekholm B., Shaw S., Jalonen P., Johansson G., Pettersson U., et al. A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet 2001, 69:96-105.
21. Lonard D.M., O'Malley B.W. The expanding cosmos of nuclear receptor coactivators. Cell 2006, 125:411-414.
22. Martorell L., Costas J., Valero J., Gutierrez-Zotes A., Phillips C., Torres M., et al. Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophr Res 2008, 100:308-315.
23. Menasce L.P., White G.R., Harrison C.J., Boyle J.M. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993, 17:263-265.
24. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., et al. Mechanisms of estrogen action. Physiol Rev 2001, 81:1535-1565.
25. Ostlund H., Keller E., Hurd Y.L. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 2003, 1007:54-63.
26. Ouyang W.C., Wang Y.C., Hong C.J., Tsai S.J. Estrogen receptor alpha gene polymorphism in schizophrenia: frequency, age at onset, symptomatology and prognosis. Psychiatr Genet 2001, 11:95-98.
27. Perlman W.R., Tomaskovic-Crook E., Montague D.M., Webster M.J., Rubinow D.R., Kleinman J.E., et al. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol Psychiatry 2005, 58:812-824.
28. Riecher-Rössler A., Häfner H. Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr Scand Suppl 2000, 58-62.
29. Riecher-Rössler A., Häfner H., Stumbaum M., Maurer K., Schmidt R. Can estradiol modulate schizophrenic symptomatology?. Schizophr Bull 1994, 20:203-214.
30. Rund B.R. Is there a degenerative process going on in the brain of people with Schizophrenia?. Front Hum Neurosci 2009, 3:36.
31. Salem J.E., Kring A.M. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev 1998, 18:795-819.
32. Sullivan P.F. Spurious genetic associations. Biol Psychiatry 2007, 61:1121-1126.
33. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008, 17:2293-2309.
34. Westberg L., Eriksson E. Sex steroid-related candidate genes in psychiatric disorders. J Psychiatry Neurosci 2008, 33:319-330.
35. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Liu Y. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol 2001, 22:33-66.
36. Wong J., Woon H.G., Weickert C.S. Full length TrkB potentiates estrogen receptor alpha mediated transcription suggesting convergence of susceptibility pathways in schizophrenia. Mol Cell Neurosci 2011, 46:67-78.